J. Lam, O. Shvarts, J. Leppert, R. Figlin, and A. Belldegrun, RENAL CELL CARCINOMA 2005: NEW FRONTIERS IN STAGING, PROGNOSTICATION AND TARGETED MOLECULAR THERAPY, The Journal of Urology, vol.173, issue.6, pp.1853-62, 2005.
DOI : 10.1097/01.ju.0000165693.68449.c3

W. Kaelin and J. , The Von Hippel-Lindau Tumor Suppressor Gene and Kidney Cancer, Clinical Cancer Research, vol.10, issue.18, pp.6290-6295, 2004.
DOI : 10.1158/1078-0432.CCR-sup-040025

F. Latif, K. Tory, and J. Gnarra, Identification of the von Hippel-Lindau disease tumor suppressor gene, Science, vol.260, issue.5112, pp.1317-1337, 1993.
DOI : 10.1126/science.8493574

J. Gnarra, K. Tory, and Y. Weng, Mutations of the VHL tumour suppressor gene in renal carcinoma, Nature Genetics, vol.88, issue.1, pp.85-90, 1994.
DOI : 10.1038/ng0594-85

J. Patard, N. Rioux-leclercq, and P. Fergelot, Understanding the Importance of Smart Drugs in Renal Cell Carcinoma, European Urology, vol.49, issue.4, pp.633-643, 2006.
DOI : 10.1016/j.eururo.2006.01.016

R. Motzer, T. Hutson, and P. Tomczak, Overall Survival and Updated Results for Sunitinib Compared With Interferon Alfa in Patients With Metastatic Renal Cell Carcinoma, Journal of Clinical Oncology, vol.27, issue.22, 2009.
DOI : 10.1200/JCO.2008.20.1293

M. Yao, M. Yoshida, and T. Kishida, VHL Tumor Suppressor Gene Alterations Associated With Good Prognosis in Sporadic Clear-Cell Renal Carcinoma, CancerSpectrum Knowledge Environment, vol.94, issue.20, pp.1569-75, 2002.
DOI : 10.1093/jnci/94.20.1569

A. Lidgren, Y. Hedberg, K. Grankvist, T. Rasmuson, J. Vasko et al., The expression of hypoxia-inducible factor 1alpha is a favorable independent prognostic factor in renal cell carcinoma, Clin Cancer Res, vol.11, pp.1129-1164, 2005.

H. Brauch, G. Weirich, and J. Brieger, VHL alterations in human clear cell renal cell carcinoma: association with advanced tumor stage and a novel hot spot mutation, Cancer Res, vol.60, pp.1942-1950, 2000.

P. Schraml, K. Struckmann, and F. Hatz, VHL mutations and their correlation with tumour cell proliferation, microvessel density, and patient prognosis in clear cell renal cell carcinoma Prevalence of von Hippel-Lindau gene mutations in sporadic renal cell carcinoma: results from The Netherlands cohort study, J Pathol. BMC Cancer, vol.196, issue.5, pp.186-93, 2002.

J. Kim, C. Jung, and Y. Cho, Somatic VHL alteration and its impact on prognosis in patients with clear cell renal cell carcinoma Genetic and epigenetic analysis of von Hippel-Lindau (VHL) gene alterations and relationship with clinical variables in sporadic renal cancer, Oncol Rep. Cancer Res, vol.13, issue.66, pp.859-64, 2005.

J. Patard, N. Rioux-leclercq, and D. Masson, Absence of VHL gene alteration and high VEGF expression are associated with tumour aggressiveness and poor survival of renal-cell carcinoma, British Journal of Cancer, vol.94, issue.8, pp.1417-1441, 2009.
DOI : 10.1186/1471-2407-5-57

URL : https://hal.archives-ouvertes.fr/inserm-00418630

L. Sobin, C. Wittekind, and . Tnm, Classification of malignant tumors. Sixth Edition, UICC International Union Against Cancer, pp.193-195, 2003.

J. Patard, P. Fergelot, and P. Karakiewicz, Low CAIX expression and absence of VHL gene mutation are associated with tumor aggressiveness and poor survival of clear cell renal cell carcinoma, International Journal of Cancer, vol.98, issue.2, pp.395-400, 2008.
DOI : 10.1002/ijc.23496

URL : https://hal.archives-ouvertes.fr/hal-00278587

F. Chen, T. Kishida, and F. Duh, Suppression of growth of renal carcinoma cells by the von Hippel-Lindau tumor suppressor gene, Cancer Res, vol.55, pp.4804-4811, 1995.

H. Cohen and F. Mcgovern, Renal-Cell Carcinoma, New England Journal of Medicine, vol.353, issue.23, pp.2477-2490, 2005.
DOI : 10.1056/NEJMra043172

C. Gallou, D. Joly, and A. Mejean, Mutations of the VHL gene in sporadic renal cell carcinoma: Definition of a risk factor for VHL patients to develop an RCC, Human Mutation, vol.8, issue.6, pp.464-75, 1999.
DOI : 10.1002/(SICI)1098-1004(1999)13:6<464::AID-HUMU6>3.0.CO;2-A

B. Rini, E. Jaeger, and V. Weinberg, Clinical response to therapy targeted at vascular endothelial growth factor in metastatic renal cell carcinoma: impact of patient characteristics and Von Hippel-Lindau gene status, BJU International, vol.61, issue.4, 2006.
DOI : 10.1016/S1535-6108(03)00187-9

X. Ma, K. Yang, P. Lindblad, L. Egevad, and K. Hemminki, VHL gene alterations in renal cell carcinoma patients: novel hotspot or founder mutations and linkage disequilibrium, Oncogene, vol.20, issue.38, pp.5393-400, 2001.
DOI : 10.1038/sj.onc.1204692

W. Hanage and D. Aanensen, Methods for Data Analysis, Methods Mol Biol, vol.551, pp.287-304, 2009.
DOI : 10.1007/978-1-60327-999-4_20

T. Choueiri, S. Vaziri, and E. Jaeger, von Hippel-Lindau Gene Status and Response to Vascular Endothelial Growth Factor Targeted Therapy for Metastatic Clear Cell Renal Cell Carcinoma, The Journal of Urology, vol.180, issue.3, pp.860-865, 2008.
DOI : 10.1016/j.juro.2008.05.015

J. Gimenez-bachs, A. Salinas-sanchez, and F. Sanchez-sanchez, Determination of vhl gene mutations in sporadic renal cell carcinoma Mutations in the von Hippel-Lindau (VHL) gene refine differential diagnostic criteria in renal cell carcinoma Comprehensive mutational analysis of the VHL gene in sporadic renal cell carcinoma: relationship to clinicopathological parameters, Eur Urol. J Surg Oncol. Genes Chromosomes Cancer. J Biol Chem, vol.49, issue.280, pp.1051-1058, 2002.

M. Hofreiter, V. Jaenicke, D. Serre, H. Av, A. Paabo et al., DNA sequences from multiple amplifications reveal artifacts induced by cytosine deamination in ancient DNA, Nucleic Acids Research, vol.29, issue.23, pp.4793-4802, 2001.
DOI : 10.1093/nar/29.23.4793

A. Marchetti, L. Felicioni, and F. Buttitta, Assessing EGFR mutations, N Engl J Med, vol.354, pp.526-534, 2006.

C. Williams, F. Ponten, and C. Moberg, A High Frequency of Sequence Alterations Is Due to Formalin Fixation of Archival Specimens, The American Journal of Pathology, vol.155, issue.5, pp.1467-71, 1996.
DOI : 10.1016/S0002-9440(10)65461-2

I. Ferrer, J. Armstrong, and S. Capellari, Effects of Formalin Fixation, Paraffin Embedding, and Time of Storage on DNA Preservation in Brain Tissue: A BrainNet Europe Study, Brain Pathology, vol.49, issue.3, pp.297-303, 2007.
DOI : 10.1097/00019606-200606000-00009

S. Shi, R. Cote, and L. Wu, DNA Extraction from Archival Formalin-fixed, Paraffin-embedded Tissue Sections Based on the Antigen Retrieval Principle: Heating Under the Influence of pH, Journal of Histochemistry & Cytochemistry, vol.125, issue.8, pp.1005-1011, 2002.
DOI : 10.1177/39.6.1709656

R. Coura, J. Prolla, L. Meurer, A. , and P. , An alternative protocol for DNA extraction from formalin fixed and paraffin wax embedded tissue, Journal of Clinical Pathology, vol.58, issue.8, pp.894-895, 2005.
DOI : 10.1136/jcp.2004.021352